Selected Readings

Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR. The Potential of Psychedelics for End of Life and Palliative Care. Curr Top Behav Neurosci. 2022;56:169-184. doi: 10.1007/7854_2021_278. PMID: 34958455.

​https://pubmed.ncbi.nlm.nih.gov/34958455/

Bahji, A., Zarate, C. A., Vazquez, G. H. (2022). Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis. Expert Opin Drug Saf. (06/21/22). 853-866. DOI: 10.1080/14740338.2022.2047928
https://pubmed.ncbi.nlm.nih.gov/35231204/

Katzman, J. (2018). Rapid depression remission and the “therapeutic bends” with ketamine-assisted psychotherapy. Psychedelics Today.
https://www.healingrealmscenter.com/blog/rapid-depression-remission-and-the-therapeutic-bends

Bennett, R. (2019). Paradigms of ketamine treatment. MAPS Bulletin, 29(1).
https://maps.org/news/bulletin/articles/436-maps-bulletin-spring-2019-vol-29,-no-1/7718-paradigms-of-ketamine-treatment-spring-2019

Oaklander, M. (2017). New hope for depression. TIME. 
https://time.com/magazine/us/4876068/august-7th-2017-vol-190-no-6-u-s/

Dore, J., Turnipseed, B., Dwyer, S., Turnipseed, A., Andries, J., Ascani, G., Monnette, C., Huidekoper, A., Strauss, N., & Wolfson, P. (2019). Ketamine assisted psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy, Journal of Psychoactive Drugs, 51(2), 189-198. DOI: 10.1080/02791072.2019.1587556
https://www.tandfonline.com/doi/full/10.1080/02791072.2019.1587556